Long-Chain Fatty Acids Alter Estrogen Receptor Expression in Breast Cancer Cells
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26146722 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ruiko Ogata und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pathology, Nara Medical University School of Medicine, Kashihara 634-8521, Japan. Hauptthemen laut MEDLINE: Breast Neoplasms, Fatty Acids, Gene Expression Regulation, Neoplastic, Estrogen Receptor alpha. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, MEXT KAKENHI.
Abstract (Originalsprache)
Long-chain fatty acids (LCFAs) have emerged as important regulators of cancer metabolism, but their impact on hormone receptor expression in breast cancer (BCA) remains poorly understood. In this study, we investigated the effects of five LCFAs—linoleic acid (LA), oleic acid (OA), elaidic acid (EA), palmitic acid (PA), and α-linolenic acid (LNA)—on two BCA cell lines: luminal-type MCF7 and triple-negative MDA-MB-231 (MB231). All LCFAs suppressed cell viability and mitochondrial function in a dose-dependent manner, accompanied by decreased membrane potential, increased reactive oxygen species production, and a metabolic shift. Notably, OA reduced both mRNA and nuclear protein levels of estrogen receptor alpha (ERα) in MCF7 cells, leading to impaired responses to estradiol and tamoxifen. In contrast, PA induced nuclear ERα expression in MB231 cells, although ER signaling remained inactive. MicroRNA profiling revealed that OA upregulated ER-suppressive miR-22 and miR-221 in MCF7, while PA increased miR-34a in MB231, contributing to ERα induction. These findings suggest that specific LCFAs modulate ER expression through epigenetic and post-transcriptional mechanisms, altering hormonal responsiveness in BCA. Our results offer new insights into how dietary lipids may influence therapeutic efficacy and tumor behavior by regulating nuclear receptor signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Pathology, Nara Medical University School of Medicine, Kashihara 634-8521, Japan.
ORCID-Profile: Hiroki Kuniyasu
Förderung
- Ministry of Education, Culture, Sports, Science and Technology
- MEXT KAKENHI
Zitieren
APA
Ogata, R., Luo, Y., Fujiwara-Tani, R., Sasaki, R., Ikemoto, A., Maehana, K., Sasaki, A., Sasaki, T., Fujii, K., Ohmori, H., & Kuniyasu, H. (2025). Long-Chain Fatty Acids Alter Estrogen Receptor Expression in Breast Cancer Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26146722
Vancouver
Ogata R, Luo Y, Fujiwara-Tani R, Sasaki R, Ikemoto A, Maehana K, et al. Long-Chain Fatty Acids Alter Estrogen Receptor Expression in Breast Cancer Cells. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26146722
BibTeX
@article{Ogata2025,
author = {Ogata, Ruiko and Luo, Yi and Fujiwara-Tani, Rina and Sasaki, Rika and Ikemoto, Ayaka and Maehana, Kaho and Sasaki, Ayaka and Sasaki, Takamitsu and Fujii, Kiyomu and Ohmori, Hitoshi and Kuniyasu, Hiroki},
title = {Long-Chain Fatty Acids Alter Estrogen Receptor Expression in Breast Cancer Cells},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26146722}
}
EUVIMED